Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace™ Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries

NCT05364502 is registered in ClinicalTrials.gov with Instylla, Inc. as lead sponsor.

NCT NCT05364502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace™ Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries
Lead sponsor
Instylla, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 12, 2022
Completion date
March 31, 2026
Enrollment
130 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

arterial bleeding in solid organs and peripheral arteries